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Specific Regional and Age-Related
Small Noncoding RNA Expression
Patterns Within Superior Temporal
Gyrus of Typical Human Brains
Are Less Distinct in Autism Brains
Boryana Stamova, PhD1, Bradley P. Ander, PhD1, Nicole Barger, PhD2,
Frank R. Sharp, MD1, and Cynthia M. Schumann, PhD2
Abstract
Small noncoding RNAs play a critical role in regulating messenger RNA throughout brain development and when altered could
have profound effects leading to disorders such as autism spectrum disorders (ASD). We assessed small noncoding RNAs,
including microRNA and small nucleolar RNA, in superior temporal sulcus association cortex and primary auditory cortex in
typical and ASD brains from early childhood to adulthood. Typical small noncoding RNA expression profiles were less distinct in
ASD, both between regions and changes with age. Typical micro-RNA coexpression associations were absent in ASD brains.
miR-132, miR-103, and miR-320 micro-RNAs were dysregulated in ASD and have previously been associated with autism
spectrum disorders. These diminished region- and age-related micro-RNA expression profiles are in line with previously reported
findings of attenuated messenger RNA and long noncoding RNA in ASD brain. This study demonstrates alterations in superior
temporal sulcus in ASD, a region implicated in social impairment, and is the first to demonstrate molecular alterations in the
primary auditory cortex.
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Whole transcriptome studies are providing new insights into the
molecular bases for normal regional heterogeneity in the human
brain.1-3 Messenger RNA signatures vary enormously between
anatomical regions and cell types, although they are highly con-
served between individuals. The human neocortex displays a rel-
atively homogeneous transcriptional pattern, and the closer the 2
cortical regions, the more similar their transcriptomes. However,
transcriptomes associated with primary sensorimotor cortices are
quite distinct from adjacent association cortex.1,2 The molecular
mechanisms responsible for normal human brain region-specific
and cell-specific gene expression patterns are not known, but
they could relate at least in part to regulatory control of small
noncoding RNA.
Small noncoding RNAs include micro-RNA, small nucleolar
RNA, and other small RNAs. Micro-RNA are *22-nucleotide
noncoding regulatory RNA that function by base-pairing with
complementary sequences in target messenger RNA. There are
more than a thousand known human micro-RNA, each targeting
dozens to several hundred target messenger RNA to predomi-
nantly promote target messenger RNA degradation or repress
messenger RNA translation. Small noncoding RNAs have criti-
cal regulatory functions in normal brain, including regulating
gene expression to coordinate brain development, neurogenesis,
neuronal maturation, cell fate specification, brain patterning, and
higher-level motor, sensory, and cognitive processes, including
learning and memory.4
Though many small noncoding RNA studies have been
performed in animals, few studies have assessed small noncoding
RNAs in the human brain.5-9 Similarly, though small noncoding
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RNAs are implicated in many brain diseases, including schizo-
phrenia, Fragile X syndrome, Rett syndrome, and autism spec-
trum disorders (ASD),10 few studies have directly investigated
the human brain. Small noncoding RNAs could play a significant
role inASD, as suggested by recent studies demonstrating that the
normal messenger RNA expression patterns typically found
between brain regions are attenuated, or less distinct, in ASD
brain.11-13 Because micro-RNA / small noncoding RNA regulate
messenger RNA, and regional differences of messenger RNA
expression are attenuated in ASD brain, we postulated that
regional differences of micro-RNA / small noncoding RNA
would also be attenuated in ASD brain. Additionally, from our
magnetic resonance imaging (MRI) and cellular postmortem
brain studies, we know that the ASD brain undergoes an aberrant
developmental trajectory across the life span,14 and therefore, we
hypothesized that age-related small noncoding RNA expression
patterns would be dysregulated in ASD brain as well.
To pursue this, we examined 2 regions in the human super-
ior temporal gyrus (STG): the superior temporal sulcus (STS)
and the primary auditory cortex (PAC). Though these regions
are adjacent to one another, they have very different brain func-
tions. The STS is association cortex, involved in social percep-
tion, joint attention, and interpreting facial gaze and speech
inputs.15-17 Abnormalities in such functions are common in dis-
orders with social impairment, including ASD.18-20 PAC is a
primary sensory cortex that modulates auditory processing, a
function not usually associated with ASD impairments. Struc-
turally, these regions exhibit distinct patterns of cellular and
neurochemical organization.15-17,21-26 Thus, from a functional
anatomic perspective, one might expect to see associated dif-
ferences in gene expression across regions in typically develop-
ing individuals.
Based on previous messenger RNA studies showing region-
specific messenger RNA expression patterns in human brains,1
we postulated that there are region-specific and age-specific
small noncoding RNA expression patterns in typically develop-
ing brains that would be attenuated, or less distinct, in ASD
brain. Thus, the objectives of this study were to (1) demonstrate
regional and age-related small noncoding RNA expression pro-
files within typical human STS and PAC that can serve as a
basis for comparison to neuropsychiatric disorders and, as an
example, (2) show how these regional and age-related profiles
may differ with aberrant development in children and adults
with ASD.
Materials and Methods
Postmortem Brain Tissue
Regional and age-related small noncoding RNA expression patterns
were assessed within 2 regions of the human superior temporal gyrus:
STS and adjacent PAC. A total of 28 human brain samples were
obtained from the Autism Tissue Program collection at the Harvard
Brain Tissue Resource Center. These included 14 fresh-frozen post-
mortem human brains; 6 typically developing brains (TYP) (6 STS
and 6 PAC samples) and 8 age-matched ASD brains (8 STS and 8
PAC samples) (Table 1). The STS included polymodal association
cortex of Brodmann area 22 and PAC included Brodmann areas 41
and 42. Samples were taken from the same coronal section in the pos-
terior portion of the temporal lobe in each brain. PAC was taken from
the crown of Heschl gyrus, where it is identified on both cytoarchitec-
tonic and functional maps,27 and the STS was taken from the dorsal,
upper wall of the STS immediately opposite the Heschl gyrus21,28 (see
Figures 1 and 2).
Small Noncoding RNA Microarray Processing
Total RNA was isolated from 10 to 75 mg of brain tissue using the
RecoverAll Total Nucleic Acid Isolation Kit (Ambion, Austin,
TX). The heat de-paraffinization step was omitted since fresh-
frozen tissue was used. Yields of RNA averaged 200 ng/mg of brain
tissue. Quality of RNA was assessed using Agilent 2100 Bioanalyzer
with the RNA 6000 Nano kit (Agilent) and RNA quantity was mea-
sured using NanoDrop ND-1000. RIN numbers ranged between 2.2
and 2.6, which is considered of low quality for messenger RNA stud-
ies. Therefore, the current study only evaluated small noncoding
RNA, which may be less affected by the lower tissue quality. Total
RNA was processed on Affymetrix micro-RNA 3.0 microarrays
according to the manufacturer’s protocol (Affymetrix, Santa Clara,
CA). All within-chip quality control hybridization metrics were
within normal ranges, indicating successful sample processing. Cel
data files were imported into Partek Genomics Suite 6.6 (Partek Inc,
St Louis, MO). Data were normalized using RMA (Robust Multichip
Averaging).
Analysis of Differential Small Noncoding RNA
Expression Between STS and PAC
Mixed effects linear regression models assessed regional small non-
coding RNA expression in typically developing (TYP) and in autism
spectrum disorders (ASD) subjects in the STS compared to the PAC
(Partek Genomics Suite 6.6). The statistical models included the fol-
lowing variables: Subject (random effect), Diagnosis (typically
developing, ASD), Region (STS, PAC), Sex (male, female), Age
(continuous variable), and an interaction term of Diagnosis*Region.
The interaction term provided the data described below and in
Table 2. Random effects included within-subject correlation among
Table 1. Demographics for Each Subject.
Case no. Primary diagnosis Sex Age, years
1 ASD F 5
2 ASD F 11
3 ASD M 15
4 ASD F 29
5 ASD M 30
6 ASD M 30
7 ASD F 49
8 ASD M 50
9 TYP F 4
10 TYP M 17
11 TYP M 24
12 TYP M 36
13 TYP F 39
14 TYP M 40
Abbreviations: ASD, autism spectrum disorders subjects; F, female; M, male;
TYP, typically developing subjects.
Stamova et al 1931
brain regions. We used the REML method of variance estimate
for unbalanced designs29 and the Fisher’s least significant differ-
ence contrast method30 to estimate regional differential small non-
coding RNA expression in each of the diagnosis groups: TYP_STS
versus TYP_PAC, and ASD_STS versus ASD_PAC. The small non-
coding RNAs with P <.005 and a |fold-change| >1.2 were considered
significant.
Analysis of Changes of Expression of Small Noncoding
RNA in the STS and PAC With Age
We performed an analysis of age-related small noncoding RNA in
STS for typically developing brain and ASD brain (Table 3), and
age-related small noncoding RNA in PAC for typically developing
brain and ASD brain (Table 4). From the lists of small noncoding
RNAs in Tables 3 and 4, we focused subsequent analyses and fig-
ures on the mature micro-RNAs (Table 5) with expression levels
>2 (n ¼ 1123 mature micro-RNAs) in all samples. We focused
on mature micro-RNA to decrease the chance for false positive
associations, and because a number of mature micro-RNA are char-
acterized experimentally and/or have high-confidence, computation-
ally predicted, sequence-specific messenger RNA targets in the
brain.
We used Spearman rank correlation coefficient (rS) as a measure of
association between micro-RNA expression levels and age in the STS
and PAC regions for both typically developing and ASD groups. rS is a
nonparametric measure of statistical dependence between 2 variables.
A perfect Spearman correlation of þ1 or 1 occurs when each vari-
able is a perfect linear function of the other. Associations between
small noncoding RNA and micro-RNA levels and age were consid-
ered significant at P <.005.
Figure 1. Differences in regional small noncoding RNA expression in the superior temporal gyrus (STG) of typically developing (TYP) subjects.
A total of 22 small noncoding RNA differed in expression between the superior temporal sulcus (STS) and the primary auditory cortex (PAC) of
the STG in typical subjects (Table 2). These 22 small noncoding RNA were subjected to a principal components analysis (PCA) and hierarchical
clustering analysis. PAC is identified by light blue and STS by an orange color. The centroids for the PCA plots indicate 2 standard deviations
around the group’s centroid, and individual subjects are indicated by the small spheres. For the hierarchical clustering, subjects are on the X-axis,
small noncoding RNA are on the Y-axis, 2-fold increase of expression is indicated by bright red color, and a 2-fold decrease of expression is
indicated by bright green color (see normalized small noncoding RNA level color bar).
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Unsupervised Hierarchical Clustering and Principal
Components Analyses
To visualize regional differences in small noncoding RNA expression,
hierarchical clustering and principal components analysis were per-
formed as described previously.31
Coexpression Analyses of Age-Related Micro-RNA
Expression in STS and PAC
Coexpression matrices were generated using the Spearman rank
correlation similarity method for regulated micro-RNAs for each
age-related analysis in STS and PAC in typically developing brains
(Partek Genomics Suite). Only significant correlations were retained
in the matrix (P < .005). Nonsignificant correlations (P  .005) were
set to zero. This coexpression matrix was imported into Genesis32 to
perform hierarchical clustering, which allows for identification of
coexpressed micro-RNA modules in TYP_STS and TYP_PAC. To
identify deviations from this coordinate expression, coexpression
matrices were derived for ASD_STS and ASD_PAC for the age-
related significant micro-RNA in the corresponding regions of typi-
cally developing brains. To evaluate how these coexpression modules
identified in typical subjects behaved in ASD, we arranged the ASD
coexpression matrices to match the hierarchical clustering order in
typically developing brains. This allowed us to visually assess devia-
tions in ASD from the patterns of typical brain development for both
STS and PAC (Figure 5).
Analysis of Micro-RNA Targets in Typically
Developing and ASD Brains
Mature micro-RNAs with region and age-related regulation in
typically developing and ASD brain were used to query databases
Figure 2. Differences in regional small noncoding RNA expression in the superior temporal gyrus (STG) of autism spectrum disorders (ASD)
subjects. A total of 11 small noncoding RNAs differed in expression between the STS (STS) and the primary auditory cortex (PAC) of the STG in
ASD subjects (Table 2). These 11 small noncoding RNAs were subjected to a principal components analysis (PCA) and hierarchical clustering
analysis. PAC is identified by light blue and STS by an orange color. The centroids for the PCA plots indicate 2 standard deviations around the
group’s centroid, and individual subjects are indicated by the small spheres. For the hierarchical clustering, subjects are on the X-axis, small
noncoding RNA are on the Y-axis, 2-fold increase of expression is indicated by bright red, and a 2-fold decrease of expression is indicated by
bright green color (see normalized small noncoding RNA level color bar). Though there are fewer small noncoding RNAs in ASD STG compared
to TYP STG, they separate PAC and STS on both PCA and cluster plots.
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of known target genes (TargetScan) as we previously described.33
Only putative targets with experimental validation or high confi-
dence of prediction, and expressed in the nervous system, were
considered for further analysis. Minor micro-RNA isoforms did not
have predicted targets in TargetScan and were not considered in the
analyses where micro-RNA targets were examined. The target
Table 2. Regionally Regulated sncRNAs Between STS and PAC in Brains of TYP and ASD Subjects.a
Regional analysis
Up in
STS vs PAC
Down in
STS vs PAC Total Transcript
TYP: STS vs PAC
Mature miRNA 4 7 11 " miR-3064-5p, miR-3189-3p, miR-4519, miR-4520b-5p
# let-7e-3p, miR-31, miR-1973, miR-3609, miR-4317, miR-4659a-5p, miR-4742-3p
Stem-Loop miRNA 2 1 3 " mir-378, mir-4314
# mir-4485
snoRNA 1 7 8 " ENSG00000238656,
# U21, U58C, U76, HBII-52-17, HBII-52-48, ENSG00000238956, ENSG00000238974
Total 7 15 22
ASD: STS vs PAC
Mature miRNA 3 0 3 " miR-187, miR-548ab, miR-583
Stem-Loop miRNA 3 1 4 " mir-3677, mir-3926 -1, mir-3926-2
# mir-1178
snoRNA 3 1 4 " 14qII-14, ENSG00000221611, ENSG00000239170
# U71d
Total 9 2 11
Abbreviations: ASD, autism spectrum disorders; miRNA, micro-RNA; PAC, primary auditory cortex; sncRNAs, small noncoding RNAs; snoRNA, small nucleolar
RNA; STS, superior temporal sulcus; TYP, typically developing.
a" denotes upregulated small noncoding RNA, and # denotes downregulated small noncoding RNA in STS compared to PAC. Numbers in the table indicate the
numbers of significantly regulated sncRNAs (P < .005, and |fold-change| > 1.2).
Table 3. Age-Regulated sncRNAs in STS in Brains of TYP and ASD Subjects.a
Age-related
analysis Increase Decrease Total Transcript
TYP-STS
Mature miRNA 10 8 18 See Table 5
Stem-Loop miRNA 2 6 8 " mir-30d, mir-1537
# mir-222, mir-548n, mir-620, mir-1248, mir-3179-3, mir-4477b
snoRNA 2 20 22 " U38A, ENSG00000202374
# ACA5, ACA13, ACA24, ACA40, ACA46, HBII-296B, U15A, U23, U31, U46, U90,
ENSG00000252543, ENSG00000200042, ENSG00000202216, ENSG00000202498,
ENSG00000208308, ENSG00000212342, ENSG00000212397, ENSG00000212551,
ENSG00000239046
Total 14 34 48
ASD-STS
Mature miRNA 1 3 4 See Table 5
Stem-Loop miRNA 3 1 4 " mir-146b, mir-640, mir-4477b
# let-7a-1
snoRNA 4 1 5 " U17a, ENSG00000239055, ENSG00000206603, ENSG00000212445
# U89
Total 8 5 13
Abbreviations: ASD, autism spectrum disorders; miRNA, micro-RNA; PAC, primary auditory cortex; sncRNAs, small noncoding RNAs; snoRNA, small nucleolar
RNA; STS, superior temporal sulcus; TYP, typically developing.
a" indicates expression of the small noncoding RNA increases with age, and # indicates expression decreases with age. Numbers indicate the numbers of
significantly regulated sncRNA (Spearman rank correlation P < .005).
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analyses revealed putative messenger RNA targets of the differen-
tially expressed mature micro-RNAs in typically developing and
ASD brain. These putative targets were subjected to IPA pathway-
enrichment analysis (Ingenuity Pathway Analysis; Qiagen) as previ-
ously described.31 A Benjamini-Hochberg multiple testing–corrected
P <.05 was considered to be statistically significant for overrepresenta-
tion of molecules in a pathway (Figure 6). Gene Ontology (GO)
enrichment analysis of putative targets was performed in DAVID
Bioinformatics Resources Functional Annotation Tool (Benjamini-
Hochberg P < .05).34,35
Test for Enrichment of Autism Spectrum
Disorders– and Other Disease-Associated Genes
To determine if the target genes of the differentially expressed
micro-RNAs relate to other diseases, we examined their enrichment
in 22 disease-related gene sets. The ASD–related gene set was from
AutDB (SFARI, MindSpec).36 The other disease-related gene sets
were from the Genotator database.37 Enrichment was assessed
in neurological diseases (Alzheimer’s, Huntington’s, Parkinson’s,
and epilepsy), psychiatric disorders (schizophrenia, major depressive
Table 4. Age-Regulated sncRNAs in PAC in Brains of TYP and ASD Subjects.a
Age-related analysis Increase Decrease Total Transcript
TYP_PAC
Mature miRNA 16 11 27 See Table 5
Stem-Loop miRNA 11 7 18 " let-7i, mir-151, mir-200c, mir-219 -1, mir-550a-1, mir-1260, mir-1285-2, mir-3138, mir-
3194, mir-4454, mir-4487
# mir-323b, mir-409, mir-485, mir-3690, mir-4476, mir-4531, mir-4797
snoRNA 8 17 25 " U71a, ENSG00000199392, ENSG00000201407, ENSG00000207217, ENSG00000238437,
ENSG00000239171, ENSG00000252119, ENSG00000252190
# 14qII-17, 14qII-20, 14qII-21, 14qII-22, ACA13, ACA5, HBI-61, HBII-210, HBII-420, HBII-99,
U45C, ENSG00000201009, ENSG00000212149, ENSG00000212528,
ENSG00000221060, ENSG00000238342, ENSG00000238390
scaRNA 0 1 1 # ACA66
Total 35 36 71
ASD_PAC
Mature miRNA 0 2 2 # miR-93-3p, miR-3607-5p
Stem-Loop miRNA 0 2 2 # mir-7-2, mir-92a-1
snoRNA 0 1 1 # ENSG00000238816
Total 0 5 5
Abbreviations: ASD, autism spectrum disorders; miRNA, micro-RNA; PAC, primary auditory cortex; scaRNA, small Cajal body–specific RNA; sncRNAs, small
noncoding RNAs; snoRNA, small nucleolar RNA; STS, superior temporal sulcus; TYP, typically developing.
a" indicates expression of small noncoding RNA increase with age, and # indicates expression of small noncoding RNA decrease with age. Numbers in the table
indicate the numbers of significantly regulated sncRNA (Spearman rank correlation P < .005).
Table 5. Age-Regulated Mature miRNAs in STS and PAC in Brains of TYP and ASD Subjects.a
Age-related analysis Increase Decrease Total Transcript
TYP_STS 10 8 18 " miR-99b-3p, miR-223, miR-320a, miR-320b, miR-320c, miR-345, miR-1234, miR-1306,
miR-2110, miR-4786-3p
# miR-103a-2-5p, mir-136-3p, miR-147b, miR-378b, miR-504, miR-1244, miR-3152-3p, miR-
4299
ASD_STS 1 3 4 " miR-1260b
# miR-424-3p, miR-484, miR-3916
TYP_PAC 16 11 27 " miR-29b, miR-29c, miR-193b-5p, miR-320a, miR-612, miR-1249, miR-2053, miR-4310,
miR-4421, miR-4440, miR-4487, miR-4506, miR-4717-3p, miR-4725-3p, miR-4740-5p,
miR-4799-3p
# miR-132, miR-132-5p, miR-370, miR-431-3p, miR-432, miR-433, miR-654-3p, miR-676-5p,
miR-2115-3p, miR-4291, miR-4804-3p
ASD_PAC 0 2 2 # miR-93-3p, miR-3607-5p
Abbreviations: ASD, autism spectrum disorders; miRNA, micro-RNA; PAC, primary auditory cortex; STS, superior temporal sulcus; TYP, typically developing.
a" indicates increasing small noncoding RNA expression with age, and # indicates decreasing small noncoding RNA expression with age. Numbers in the table
indicate the numbers of significantly regulated mature miRNA (Spearman rank correlation P < .005).
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disorders, bipolar disorders, obsessive-compulsive disorders, panic
disorders, dissociative disorders) and neurodevelopmental disorders
(autism spectrum disorders, Angelman syndrome, Asperger’s syn-
drome, developmental delay, Fragile X syndrome, Prader-Willi syn-
drome, Rett syndrome, Tourette syndrome, tuberous sclerosis,
microcephaly, macrocephaly, Timothy syndrome). Enrichment was
tested using the hypergeometric probability function phyper in R,
with the population size set to 20 687 (all protein-coding genes in
the human genome).38 A Bonferroni correction for multiple compar-
isons was considered significant (Bonferroni P < .05, –log10[Bonfer-
roni-corrected P] >1.3) (Figure 7).
Nervous System Functions Common to Micro-RNA
Targets and SFARI Database
The 11 mature micro-RNA that were differentially expressed between
STS and PAC in typical subjects (see results below) had 844 putative
messenger RNA targets (TargetScan). Of these 844 messenger RNA
targets, a total of 40 genes overlapped with the 573 autism-implicated
genes from the SFARI AutDB database (P < .05). These 40 genes were
used as an input into the Ingenuity Pathway Analysis Knowledge Base
and the top 10 enriched nervous system functions were identified with a
P < .05 (Figure 8).
Figure 3.Mature micro-RNAs that change expression with age in STS (STS) and primary auditory cortex (PAC) of typical subjects. Typical STS
(TYP_STS) is shown on the left and typical PAC (TYP_PAC) on the right. The heat map on the left is for STS and on the right is for PAC. The heat
maps represent the strength of the age-related association with the expression levels of the regulated micro-RNAs in TYP_STS or TYP_PAC
(Spearman rank correlation, rS values) compared to their corresponding associations in ASD_STS and ASD_PAC, respectively (dark red, rS ¼
þ1; dark blue, rS¼ –1). Scatter plots for the top 2 positive age-correlating mature micro-RNAs (miR-320a, miR-345) and the top 2 negative age-
correlating micro-RNAs (miR-378b, miR-4299) for STS are shown on the left. Scatter plots for the top 2 positive age-correlating micro-RNAs
(miR-4487, miR-4725-3p) and the top 2 negative age-correlating micro-RNAs (miR-132, miR-432) for PAC are shown on the right. Micro-RNAs
displayed in scatter plots are underlined in heat maps. For the scatter plots, micro-RNA expression is on the Y-axis, age is on the X-axis (4-40
years of age), males are indicated by black dots, and females by gray dots.
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Results
Subject Characteristics
Demographic and clinical characteristics of the subjects are
listed in Table 1. There were 12 typically developing brain sam-
ples (6 STS and 6 PAC) from subjects 26.7+ 14.4 years of age
(range 4-40 years), of whom 66.6% were male. There were 16
ASD samples (8 STS and 8 PAC) from subjects 27.4 + 16.6
years of age (range 5-50 years) of whom 50% were male. There
were no significant differences (P > .05) in age, postmortem
interval or sex between the typically developing control and
ASD groups. Additional information on subject medication/drug
use, comorbidities, cause of death, and agonal state were limited
and therefore not included in analyses.
Figure 4.Mature micro-RNAs that change expression with age in superior temporal sulcus (STS) and primary auditory cortex (PAC) of autism
spectrum disorders (ASD) subjects. The STS (ASD_STS) is shown in the left 2 panels and PAC (ASD_PAC) on the right. The heat maps rep-
resent the strength of the age-related association with the expression levels of the regulated micro-RNAs in ASD_STS or ASD_PAC (Spearman
rank correlation, rS values) and their corresponding associations in TYP_STS and TYP_PAC, respectively (dark red, rS¼þ1; dark blue, rS¼ –1).
Scatter plots on the left are shown for the one positive age-correlating and 3 negative age-correlating mature micro-RNA in ASD STS, and the
scatter plots on the right are shown for the 2 negatively correlating mature micro-RNA in ASD PAC. For the scatter plots, micro-RNA
expression is on the Y-axis, age is on the X-axis (5-50 years of age), males are indicated by black dots, and females by gray dots. TYP. typically
developing brains.
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Regional Differences of Small Noncoding RNA
Expression Between STS and PAC
Typical subjects. In typically developing control brains, there
were 22 small noncoding RNAs differentially expressed
between STS and PAC (P < .005, |fold change| >1.2) (Table 2)
in the superior temporal gyrus. Principal components analy-
sis and unsupervised hierarchical clustering of the 22 small
noncoding RNAs demonstrated good separation of STS and
PAC in typically developing brains (Figure 1). Eleven of the
22 small noncoding RNAs that differed in typical STS com-
pared to PAC were mature micro-RNA, 3 were stem-loop
precursor micro-RNA, and 8 were small nucleolar RNA
(Table 2).
Autism spectrum disorders subjects. In ASD brains, there were 11
small noncoding RNAs differentially expressed between the
STS and PAC (P < .005, |fold change| >1.2) (Table 2). Princi-
pal components analysis and unsupervised hierarchical clus-
tering of the 11 small noncoding RNAs demonstrated good
separation of STS and PAC in ASD brains (Figure 2). Three
of the 11 small noncoding RNA that differed in ASD STS
compared to the PAC were mature micro-RNA, 4 were
stem-loop precursor micro-RNA, and 4 were small nucleolar
RNA (Table 2). None of the small noncoding RNA differen-
tially expressed between the STS and PAC in ASD brains
were the same as those differentially expressed in typically
developing control brains (Table 2). There were only upregu-
lated mature micro-RNAs in ASD (expressed higher in STS than
in PAC), whereas there were upregulated and downregulated
micro-RNAs (expressed lower in STS compared to PAC) in
typically developing brains.
Age-Related Changes of Small Noncoding RNA
Expression in STS
Typical subjects’ STS. In the STS of typically developing brains, a
total of 48 small noncoding RNA changed expression as a func-
tion of age (P < .005) (Table 3). Eighteen of the 48 were mature
micro-RNA, of which 10 increased expression with age and 8
decreased expression with age in STS (Tables 3 and 5). Figure
3 (left panels) shows the strength of the association of the
expression of these 18 mature micro-RNAs with age in typi-
cally developing brains compared to that in ASD subjects (heat
map shows Spearman rank correlation coefficients, rS: dark
red, þ1, dark blue, –1). Note that most positively correlated
Figure 5. Coexpression relationships for micro-RNAs that changed expression as a function of age in the superior temporal sulcus (STS) (left
panel) and in the primary auditory cortex (PAC) (right panel). The coexpression relationships for mature micro-RNA in typical subjects are
above the white diagonal line for STS and PAC. The coexpression relationships for the corresponding mature micro-RNA in autism spectrum
disorders (ASD) subjects are below the white diagonal line for STS and PAC. Bright red ¼ Spearman rank correlation coefficient of þ1; bright
green ¼ Spearman rank correlation coefficient of –1. Nonsignificant correlations (P .005 were set to 0, black). Most of the coexpression
relationships observed in typically developing brains are absent in ASD for both STS and PAC.
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micro-RNA in typically developing brains were also positively
correlated in ASD except that their rS were not significant; and
most negatively correlated micro-RNA in typically developing
brains were also negatively correlated in ASD except that their
rS were not significant. Figure 3 also shows scatter plots (left
panels) of the top 2 positive associations with age (miR-
320a, miR-345) and the top 2 negative associations with age
(miR-378b, miR-4299) in typically developing brain STS for
males (black dots) and females (gray dots).
Autism spectrum disorders subjects’ STS. In the STS of ASD
brains, a total of 13 small noncoding RNA changed expres-
sion as a function of age (P < .005) (Table 3), with 4 being
mature micro-RNA, of which 1 increased expression with age
and 3 decreased expression with age (Tables 3 and 5). Figure
4 (left panels) shows the strength of the association of the
expression of these micro-RNAs with age in ASD versus typi-
cally developing brains (heat map shows Spearman rank cor-
relation coefficients: dark red, þ1, dark blue, –1). Two of the
negatively correlated micro-RNA in ASD were positively
correlated in typically developing brains (though their rS were
not significant). Figure 4 also shows the scatter plots (left 2
panels) of the positive association with age for miR-1260B
and negative associations with age for miR-484, miR-424-
3p, and miR-3916 in ASD STS for males (black dots) and
females (gray dots).
Age-Related Differential Small Noncoding RNA
Expression in PAC
Typical subjects PAC. In the PAC of typical brains, a total of 71
small noncoding RNA changed expression as a function of age
(P < .005) (Table 4), with 27 being mature micro-RNA, of
which 16 increased expression with age and 11 decreased
expression with age in typically developing brain PAC (Tables
4 and 5). Figure 3 (right panels) shows the strength of the asso-
ciation of the expression of the 27 micro-RNAs with age in
typically developing brains compared to ASD (heat map shows
Spearman rank correlation coefficients: dark red, þ1; dark
blue, –1). Several of the micro-RNA positively correlated with
age in typically developing brains were negatively correlated in
ASD (though their rS were not significant). One of the nega-
tively correlated micro-RNA in typically developing brains
was positively correlated with age in ASD (though its rS was
not significant). Figure 3 also shows scatter plots (far right
panels) of the top 2 positive associations with age (miR-
4487, miR-4725-3p) and the top 2 negative associations with
age (miR-132, miR-432) in typical PAC for males (black dots)
and females (gray dots).
Autism spectrum disorders subjects PAC. In the PAC of ASD
brains, a total of 5 small noncoding RNA changed expression
as a function of age (P < .005) (Table 4), with 2 of the 5 being
Figure 6. Enrichment of nervous system pathways that are targets of regulated micro-RNA in typically developing (TYP) and autism spectrum
disorders (ASD) brains. The messenger RNA targets for the 11 mature micro-RNA (Table 2) differentially expressed in typical STS compared to
primary auditory cortex (PAC) were determined using TargetScan. Similarly, the messenger RNA targets for the 3 mature micro-RNA (Table 2)
differentially expressed in ASD STS compared to PAC were determined using TargetScan. Both sets of messenger RNA targets were inputed
into Ingenuity Pathway Analysis and significantly regulated pathways identified. For the figure, significant pathways are above the thin black line
(Benjamini-Hochberg [B-H]–corrected P <.05, corresponding to –log10[B-H P value] >1.3). Black bars indicate typical STS versus PAC pathways;
and grey bars indicate ASD STS versus PAC pathways. Note that there are pathways common to TYP and ASD, as well as pathways specific for
TYP subjects and specific for ASD subjects.
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mature micro-RNA, both of which decreased expression with
age in ASD_PAC (Tables 4 and 5). Figure 4 (far right panels)
shows the strength of the association of the level of these 2
micro-RNAs with age in ASD compared to typically develop-
ing brains, as well as the scatter plots of these negative associa-
tions for miR-3607-5p and miR-93-3p in ASD_PAC for males
(black dots) and females (gray dots).
Coexpression Analyses of Micro-RNA that Changed
With Age in STS and PAC
STS. The coexpression analysis of the age-associated mature
micro-RNA in the STS of typical subjects revealed modules
of negative (green) and positive (red) associations in typically
developing subjects (Figure 5, left panel, triangle above diago-
nal). In contrast, the coexpression analysis yielded quite differ-
ent results in the STS of ASD subjects with apparent loss of
most of the significant negative and positive associations in
ASD subjects (Figure 5, left panel, triangle below diagonal).
PAC. Similarly, the coexpression analysis of the age-associated
micro-RNA in the PAC revealed modules of negative (green)
and positive (red) coexpression relationships in the age-
associated mature micro-RNAs in the PAC of typical controls
(Figure 5, right panel, triangle above diagonal). In contrast,
the coexpression pattern is different in the PAC of ASD sub-
jects with apparent loss of most of the significant negative and
positive associations in ASD subjects (Figure 5; right panel,
triangle below diagonal).
Overlap of Micro-RNA in This Study With Previous
Autism Spectrum Disorders Micro-RNA Studies
The overlap of our findings with dysregulated micro-RNAs
reported in previous ASD studies is shown in Table 6.39-42 We
found 58 mature micro-RNAs differentially expressed by region
or age in the STS or PAC either in typically developing brains or
in ASD. Of these, 11 micro-RNAs or their gene family members
have been reported to be dysregulated in ASD cerebellar cor-
tex39 and/or ASD lymphoblastoid cell lines40-42 (Table 6). Seven
of the 11 micro-RNAs (miR-93, miR-132, miR-193, miR-320,
miR-431, miR-432, miR-484) have been reported to be signifi-
cantly differentially expressed in subsets of ASD brain samples
of cerebellar cortex compared to the non-ASD control set (out of
their 28 significant micro-RNAs, with 26 unique family IDs, P
of overlap ¼ .0002) (Table 1, from Abu-Elneel et al39). Five
micro-RNAs were differentially expressed in the
lymphoblastoid cell lines of affected versus unaffected
monozygotic twins discordant for ASD diagnosis or ASD
severity (out of their 43 significant micro-RNAs, with 39
unique micro-RNA family IDs, P of overlap ¼ .046) (Table 1,
from Sarachana et al40). Two micro-RNAs (miR-132, miR-
320) were differentially expressed in lymphoblastoid cell lines
between ASD and controls (out of their 9, with 7 unique
micro-RNA family IDs, P of overlap ¼ .047) (Table 1, from
Talebizadeh et al42). One micro-RNA (miR-548) was
differentially expressed in the lymphoblastoid cell lines
between ASD–affected siblings versus unaffected siblings (out
of their 12 significant micro-RNAs, with 10 unique micro-
RNA family IDs, P of overlap ¼ .413, nonsignificant) (Table
2, from Ghahramani Seno et al41).
Messenger RNA Target Pathways of Differentially
Expressed Micro-RNAs for the Superior Temporal
Sulcus Versus the PAC
There were 11 micro-RNAs in typical brains that were differ-
entially expressed between the STS and PAC (Table 2), which
had a total of 844 predicted messenger RNA targets (TargetS-
can). In contrast, there were only 3 differentially expressed
micro-RNAs in the ASD brain between the STS and the PAC
(Table 2), which had a total of 51 predicted messenger RNA
targets. Based on these messenger RNA targets, biological
Figure 7. Enrichment in putative messenger RNA targets of the
regionally and age-regulated mature micro-RNAs in typical brains that
differ from autism spectrum disorders (ASD) brains and are associated
with specific diseases. For this analysis, we determined whether the
putative messenger RNA targets for the 11 micro-RNA in the
TYP_STS versus PAC analysis (black bars), the 18 micro-RNA in the
TYP_STS age-related analysis (cross-hatched bars), and the 27 micro-
RNA for the TYP_PAC age-related analysis (white bars) were signifi-
cantly enriched in messenger RNA gene sets from 22 different dis-
eases. The figure shows only 11 diseases for which the Bonferroni-
corrected P was <.05 (log10[Bonferroni-corrected P] >1.3; dotted
line) for at least one of the regional- or age-related analyses.
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processes for neuron function, synaptic transmission, and tran-
scription were enriched in typical brains, but not in ASD brains
(unpublished data, available on request).
To provide one example of the effect of the dysregulated
micro-RNA on functional pathways, we compared the messen-
ger RNA targets for micro-RNA differentially expressed in
typically developing brain STS versus PAC and the messenger
RNA targets for micro-RNA differentially expressed for ASD
STS versus PAC for nervous system functional pathways (Fig-
ure 6). The canonical pathways derived from those messenger
RNA targets showed some pathways specific for typical brain,
some specific for ASD brain, and some pathways shared by
both (Figure 6). Note that the dysregulated micro-RNA in ASD
brain would result in dysregulation of pathways such as ephrin
receptor, ephrin B, netrin, and reelin signaling in the ASD brain
(Figure 6, typically developing brain–specific), and aberrant
regulation of pathways, such as NGF, neurotrophin, CNTF, and
melatonin signaling (Figure 6, ASD-Specific). In spite of these
many abnormalities there are a number of pathways shared
between typically developing and ASD subjects (Figure 6)—
even though the micro-RNA implicated in the shared pathways
were different for typically developing compared to ASD sub-
jects (Tables 4 and 5).
Putative Messenger RNA Targets of Differentially
Expressed Micro-RNA Implicated in Disease
We next showed that target genes of the micro-RNA that
varied as a function of region and age in typically develop-
ing brains but not in ASD (and were therefore dysregulated
in ASD) have been implicated in a variety of diseases
(Figure 7). Both region- and age-related micro-RNA target
Figure 8. Top 10 enriched nervous system–related biological functions among the genes overlapping between the micro-RNA targets in
typically developing regional analysis and autism-implicated genes. Of the 844 messenger RNA targets of the 11 mature micro-RNA (Table 2)
in the typical superior temporal sulcus (STS) versus primary auditory cortex (PAC) analysis, there were 40 genes that overlapped with the
573 autism-implicated genes from the SFARI AutDB database (P < .05) (data provided on request). These 40 genes were inputed into an
Ingenuity Pathway Analysis to yield the top 10 nervous system–related functions shown in light yellow (P < .05). Of the 40 genes, 18 genes
(shown in light purple) were most associated with these top 10 functions.
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genes in superior temporal gyrus of typically developing
brains have been implicated in ASD (Figure 7). However,
targets of the ASD–dysregulated micro-RNAs are not spe-
cific for ASD–associated genes, because they are associated
with many other disorders (Figure 7). Significant associa-
tions for typically developing brain STS versus PAC,
TYP_STS age-related, and TYP_PAC age-related are
obtained for ASD–implicated genes, as well as schizophre-
nia, manic depressive disorders, and Alzheimer’s disease
(Figure 7).
Messenger RNA Targets of Dysregulated Micro-RNA
Overlap With Autism-Implicated Genes
There were micro-RNAs differentially regulated in STS com-
pared to the PAC of typical subjects that had messenger RNA
target genes that are implicated in ASD. These micro-RNAs are
important for ASD because they were regulated in typical but
not ASD brains. Of the 844 messenger RNA targets of the 11
micro-RNAs (Table 2) in the typical STS versus PAC analysis,
there were 40 genes that overlapped with the 573 autism-
implicated genes from the SFARI AutDB database (P < 0.05)
(data provided on request). These 40 genes were inputted into
an Ingenuity Pathway Analysis to yield the top 10 nervous sys-
tem functions (P < .05) (Figure 8). The 18 genes most associ-
ated with these top 10 functions are also shown (Figure 8).
Among the 18 genes were those involved in neurotransmission
(hypergeometric probability of overlap P ¼ 2.4  10–9),
including neuroligin 3, Homer homolog 1, ionotropic gluta-
mate receptor, synapsin 2, voltage-gated sodium channels,
protocadherin 8, and eukaryotic translation initiation factor
4E–binding protein 2 (Figure 8). Glutamate receptor signaling
was also specifically enriched (P ¼ .01).
Similarly, there were also age-regulated micro-RNAs in
STS and PAC of typical subjects which had messenger RNA
targets implicated in ASD. These micro-RNAs are important
for ASD because they were regulated in typical but not ASD
brains. For the 18 micro-RNAs regulated as a function of age
in typical STS (Table 5), these had 1591 messenger RNA
targets (TargetScan), of which 83 were shared with the 573
autism-implicated genes from the SFARI AutDB database
(P < .05). For the 27 micro-RNA regulated as a function of age
in typical PAC but not ASD PAC (Table 5), these had 2867
messenger RNA targets (TargetScan), of which 169 were
shared with the 573 autism-implicated genes from the SFARI
AutDB database (P < .05) (data for all of the above analyses
provided on request).
Discussion
As we postulated, specific expression patterns of micro-RNA
and other small noncoding RNA differ significantly between
STS and PAC within normal human superior temporal gyrus
and change significantly with age. In contrast, there were
fewer differences of micro-RNA / small noncoding RNA
between STS and PAC in ASD brain, and there was loss of
the typical age-related changes. Given that micro-RNAs/
small noncoding RNAs regulate many messenger RNA
targets, this likely contributes to the attenuated messenger
RNA expression patterns recently reported between regions
in ASD brain compared to typical brains.11,13 Moreover, a
number of micro-RNA gene targets regulated in the STS
and PAC of typical but not ASD subjects are ASD
candidate genes.36 The lack of differentiation in micro-RNA-
mediated transcriptional changes in ASD brain would affect
axon guidance, dendritic growth, synaptic plasticity,
neurotransmission, and other processes that likely contribute
to ASD pathophysiology.43,44
Role of Micro-RNA/Small Noncoding RNA
in Typically Developing Superior Temporal Gyrus
Recent whole genome studies of human brain show tremen-
dous brainwide variation in differential gene expression and
coexpression relationships.1 Though the neocortex displays
a relatively homogeneous transcriptional pattern, there are
distinct transcriptome signatures associated with primary
sensorimotor cortices including the PAC.1 Given the many
micro-RNA and other small noncoding RNA differentially
expressed in the PAC compared to STS in this study as a
function of brain region and age, and the fact that micro-
RNA regulate dozens to a few hundred messenger RNA tar-
gets each, it is likely that the micro-RNA/ small noncoding
RNA differences in the PAC and STS observed in this
study explain many of the transcriptional messenger RNA
differences observed in typically developing superior tem-
poral gyrus reported in other studies.1 Region-specific
Table 6. Overlap of the Micro-RNA Regulated in This Study
Compared With Other Studies of ASD Micro-RNA Transcriptomes.
STS, PAC
ASD, TYP
this study
Cerebellar cortex
ASD vs
control39
LCL
ASD vs
control40
LCL
ASD vs
control42
LCL
ASD vs
control41
miR-93-3p miR-93 miR-93
miR-132
miR-132-5p
miR-132 miR-132 miR-132
miR-193b-5p miR-193b
miR-320a
miR-320b
miR-320c
miR-320a miR-320
miR-431-3p miR-431
miR-432 miR-432
miR-484 miR-484
miR-29b
miR-29c
miR-29b
miR-103a-2-5p miR-103
miR-136-3p miR-136
miR-548ab miR-548o
Abbreviations: ASD, autism spectrum disorders; LCL, lymphoblastoid cell lines;
PAC, primary auditory cortex; STS, superior temporal sulcus; TYP, typically
developing controls.
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micro-RNA/ small noncoding RNA likely regulate cascades
of genes that mediate either specific cognitive functions in
STS or auditory processing in the PAC and may also have
region-specific roles in learning and memory.4,45-47
Attenuated Regional and Age-Related Micro-RNA / Small
Noncoding RNA in ASD Superior Temporal Sulcus and
Primary Auditory Cortex
The small noncoding RNA and micro-RNA expression patterns
in the STS and PAC discussed above for typical human brains
were markedly attenuated in ASD brains. If one considers the
predicted brain messenger RNA targets of the mature micro-
RNAs in ASD compared to typical brains, this translates to
16 times fewer putative targets in the STS and PAC of ASD
(51 targets) compared to typical (844 targets) brains. Notably,
fewer messenger RNA and long noncoding RNA differences
have been reported among ASD brain regions. Regional mes-
senger RNA differences between the frontal and temporal cor-
tex are attenuated in ASD brain,11 and there are fewer
messenger RNA and long noncoding RNA differences between
the prefrontal cortex and cerebellum of ASD brain compared to
controls.11,13 It is possible that decreased numbers of regulated
messenger RNA in the ASD cortex may be related to decreased
numbers of regulated micro-RNA. Alternatively, these results
may be due to general dysregulation of transcription.
In addition, fewer small noncoding RNAs / micro-RNAs
changed expression with age in ASD compared to typical
brains. Previous studies show that many micro-RNAs are
regulated in an age-dependent manner in normal human
brains.8,48 We found that several more small noncoding
RNAs / micro-RNAs changed with age in typical STS com-
pared to ASD STS. Given STS is a primary component of
the ‘‘social brain’’17 and there are structural changes in the
temporal lobe of ASD subjects,49 the aberrant attenuated
micro-RNA expression in ASD STS suggests aberrant
molecular functions that likely contribute to core social
abnormalities in ASD.
Surprisingly, dysregulation of small noncoding RNAs in
ASD was not limited to STS association cortex. The PAC in
ASD also showed decreased numbers of age-regulated micro-
RNA and drastically altered coexpression modules compared
to typical development. Though ASD is not usually thought
to be associated with sensory abnormalities, ASD subjects
often have auditory, visual, and tactile hyperreactivity or
hyporeactivity.50,51 Moreover, enhanced auditory perception
and acoustic startle response to weak stimuli are thought to
contribute to atypical auditory processing in ASD52 and is
reported to interrupt behavioral adaptation.53 Though it is
unclear whether molecular changes in the PAC contribute to
core ASD symptoms, the PAC is interconnected with STS and
other social brain regions and thus could contribute to circuit
dysfunction in ASD. Moreover, age-related attenuation of
small noncoding RNA responses in ASD PAC suggests life-
long abnormalities in superior temporal gyrus circuitry.
Role of Specific Micro-RNA in Superior Temporal Gyrus
of Typical and ASD Brains
There were 2 classes of ASD–related, dysregulated small non-
coding RNA/micro-RNA identified in this study: (1) those that
were regionally or age regulated in typical human brain but not
in ASD brain and (2) those that were regionally or age regulated
in ASD but not in typical brain. The first class would result in
failure to regulate typical messenger RNA targets in ASD brain,
and the second class would result in aberrant regulation of mes-
senger RNA targets in ASD brain. Both would contribute to
abnormal molecular pathology in ASD, though it is possible that
the second class contributes to compensatory functions.
Though all of the dysregulated small noncoding RNA,
including micro-RNA, reported in this study would bind a
number of target messenger RNA/genes and regulate their
function, the specific functions of only a few have been identi-
fied in the brain. Indeed, all of the micro-RNA reported here
will require further study in cellular and animal models to
assess their role in normal brain. To date, only miR-132,
miR-103, miR-320, and miR-378—the family members of
which are dysregulated in this study—have been studied in the
human brain. Each is discussed briefly below.
miR-132 decreases with age in the PAC of typical brains and
has an established role in brain development and disease.44,54,55
It is regulated by neuronal activity and neurotrophins, it
increases dendritic spine density and size, and promotes mature
spine morphology.56-59 miR-132 regulates dendritic spine mor-
phology in an experience-dependent manner to maintain plas-
ticity.60-62 Thus, miR-132 could relate to the alterations in
dendritic spine density reported in ASD brain.63,64
Though miR-132 decreases with age in the PAC in the typ-
ical human brain, it does not in ASD brain. Altered miR-132
expression is reported in the cerebellum and lymphoblastoid
cell lines in ASD and in the prefrontal cortex in schizophre-
nia.39,40,42 Moreover, miR-132 regulates the MeCP2 gene,
which is mutated in Rett syndrome, an X-linked disorders with
shared features of, and often comorbid with, ASD.65 These
findings suggest that miR-132 is required for brain plasticity,
and its dysregulation could contribute to aberrant cortical
maturation seen in the ASD brain.49,66
miR-103a-2-5p is downregulated with age in typical STS in
this study, and miR-103 is downregulated with age in typical
human dorsolateral prefrontal cortex.48 miR-103, along with
other micro-RNA, is involved in fine-tuning of neuronal migra-
tion.67 The normal downregulation of miR-103a-2-5p with age
in the STS does not occur in ASD brain. miR-103 is differen-
tially expressed in lymphoblastoid cell lines of monozygotic
twins discordant for ASD.40 miR-103 targets are enriched in
the genomic regions of long noncoding RNAs that are dysregu-
lated in ASD brain.13 This may contribute to aberrant neuronal
connectivity in ASD circuits,68 and, along with its role in neu-
ronal migration, suggests miR-103 plays a potential role in
ASD neuropathology.
miR-320 family members are found to increase with age
in typical human STS and PAC in this study, whereas
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micro-RNA-320 decreases with age in the prefrontal cortex.8
miR-320 induces neurite outgrowth, increases neurite length,
decreases proliferation of Neuro-2A (N2A) cells,69 responds
to oxidative stress, and regulates glycolysis.70 Because miR-
320 does not increase with age in ASD as it does in typical
superior temporal gyrus, this might relate to ASD developmen-
tal abnormalities and perhaps to mitochondrial dysfunction
reported in ASD.71
miR-378b expression in typical human brains decreases
with age in STS, and hp_mir-378 (stem-loop precursor) is over-
expressed in the STS versus PAC. miR-378 together with other
micro-RNAs modulates learning, memory, and exploration
behavior.72 Because age-related changes of miR-378b are not
observed in ASD STS, miR-378b could contribute to ASD
pathophysiology as well.73
Role of Small Nucleolar RNAs in Superior Temporal
Gyrus of Typical and ASD Brains
Other classes of small noncoding RNA displayed regional and
age-related regulation in typical brain including small nucleo-
lar RNAs, such as HBII-48 and HBII-52. Their rodent homo-
logs, MBII-48 and MBII-52, affect learning and memory in
mice.74,75 HBII-52 regulates 5-HT2C receptor subunit messen-
ger RNA and loss of function of MBII-52 increased serotonin
2C receptor pre-RNA editing and altered 5HTR-2C-mediated
behavior.76 These small nucleolar RNAs were dysregulated
in ASD brains in this study, and could relate to studies that have
reported 5HT abnormalities in ASD.77
HBII-48 and HBII-52 (SNORDs115) are both located on
chromosome 15q11.2, which is notable since maternally inher-
ited duplications involving chromosomal region 15q11–15q13
are among the most common chromosomal abnormalities in
ASD.78 In addition, small nucleolar RNA MB-II-52 regulates
alternative splicing,79,80 which is of interest because abnormal-
ities of alternative splicing have been reported in the brain11 as
well as blood31 of patients with ASD.
Conclusions
Here we found that in 2 structurally and functionally distinct
regions of the superior temporal gyrus, STS, and PAC, there are
differential expression patterns of small noncoding RNAs.
These specific expression patterns, in addition to appropriate
coexpression of micro-RNAs, for different brain regions as
well as changes with age are required to shape a typical human
brain and produce neurotypical function throughout the life
span. These patterns were not observed in ASD brains, likely
contributing to dysregulation of messenger RNA and conse-
quently alterations in brain structure and function. If fact, the
micro-RNA families found to be dysregulated in the current
study have previously been associated with neurodevelopmen-
tal disorders. Aberrant small noncoding RNA expression pat-
terns were not limited to the region commonly associated
with ASD social impairments, the STS, but also present in a
primary sensory region, the PAC. The lack of differential
regional and age-related small noncoding RNA expression pat-
terns in ASD brain support findings of attenuated messenger
RNA expression profiles, which consequently would pro-
foundly alter typical human brain development and function.
Future studies will need to confirm these findings in a larger
sample size with high-quality brain tissue, as well as assess-
ment of small noncoding RNA and messenger RNA in the
same human brain samples.
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